EN
HI
Summary
As of 7 Nov, 2026, Aarti Pharmalabs stock price is ₹929.1. During the trading session, the stock has moved between an intraday low of ₹900.00 and an intraday high of ₹932.70. Over the last 52 weeks, Aarti Pharmalabs has traded between ₹585.00 and ₹1002.40.
The stock has recorded a trading volume of 4,34,680 shares,. Its Average Traded Price (ATP) is ₹914.50, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹929.10.
Aarti Pharmalabs has an upper circuit limit of ₹1113.95 and a lower circuit limit of ₹742.65. The total value traded stands at ₹39.75 CR, and the delivery percentage for the day is 44.5%.
The stock is currently traded with a market lot size of 1. Aarti Pharmalabs also offers a dividend yield of 0.38%.
Aarti Pharmalabs Share Price Chart
Aarti Pharmalabs Share Key Metrics
Volume
4.35 L
Market Cap
8425.06 CR
LTQ@LTP
1@929.10
ATP
914.5
Var Margin
22.9 %
Circuit Range
742.65-1113.95
Delivery %
44.5 %
Value
39.75 CR
ASM/GSM
No
Market Lot
1
Aarti Pharmalabs Fundamentals
P/E Ratio
32.8
P/B Ratio
3.73
Div. Yield
0.38
Sector P/E
40.39
Sector P/B
3.37
Sec. Div. Yield
0.53
Aarti Pharmalabs Resistance and Support
Pivot 930.78
Resistance
First Resistance
944.01
Second Resistance
959.73
Third Resistance
972.96
Support
First Support
915.06
Second Support
901.83
Third Support
886.11
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 06 2026 | 920 | 929.1 | 0.09% | 932.7 | 900 |
| Thu Nov 05 2026 | 945 | 928.29 | 0.19% | 946.5 | 917.54 |
| Wed Nov 04 2026 | 927.4 | 926.5 | 0.71% | 934.5 | 912.59 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 28, 2026
Aarti Pharma reported Q2 FY27 cons. revenue of ₹610.45 crore (up 46% YoY) and a net profit of ₹71.47 crore (up 248% YoY). In a leadership transition, the company appointed Vibha Thakkar as the new CFO, succeeding Piyush Lakhani who resigned to pursue alternate opportunities.
Oct 28 2026 20:55:17
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Yatharth Hospital & Trauma Care Services Ltd.
1026.95
-0.30 (0.03%)
Strides Pharma Science Ltd.
999.60
-8.00 (0.79%)
Healthcare Global Enterprises Ltd.
600.25
-10.65 (1.74%)
Jupiter Life Line Hospitals Ltd.
287.60
1.05 (0.37%)
Procter & Gamble Health Ltd.
5556.00
-49.00 (0.87%)
Paras Healthcare Ltd.
734.55
-39.65 (5.12%)
Sanofi India Ltd.
3283.10
-92.70 (2.75%)
Symbiotec Pharmalab Ltd.
1513.60
242.10 (19.04%)
Thyrocare Technologies Ltd.
493.10
3.35 (0.68%)
Suven Life Sciences Ltd.
264.85
-11.25 (4.07%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 929.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 32.8. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.73. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 40.39 & 3.37 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 8425.06 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 1002.40 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
